[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)
Report ID: AA0723545
The global market for preimplantation genetic diagnosis (PGD) is expected to reach new heights by 2031, with an estimated value of 198,603.5 thousand US dollars.
The global preimplantation genetic diagnosis (PGD) market has achieved remarkable growth, providing hope and advanced solutions for individuals and couples aiming to expand their families. The sales revenue in 2022 was approximately \$81,520.2 thousand, but it is estimated to soar to \$198,603.5 thousand by 2031, with a steady compound annual growth rate (CAGR) of 10.4% projected during the forecast period from 2023 to 2031. The global PGD market is at the forefront of technological innovation in reproductive medicine. With advancements in medicine, the ability to conduct genetic testing on preimplantation embryos has significantly changed family planning. PGD enables individuals and couples to make informed decisions by identifying genetic abnormalities, hereditary diseases, and chromosomal abnormalities that could affect the health of future children. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.
Inquire About This Product
basic information
Overview of Segmentation The global preimplantation genetic diagnosis (PGD) market segmentation focuses on the types of tests and regions. By Test Type Chromosomal Abnormalities Aneuploidy X-linked Diseases Single Gene Disorders HLA Typing Sex Selection Others Key Companies: Reproductive Genetic Innovations (RGI) Agilent Technologies Quest Diagnostics Invitae Corporation PerkinElmer Laboratory Corporation of America Holdings Illumina Inc CeGat GmbH PacGenomics Natera Inc
Price range
Delivery Time
P1
Applications/Examples of results
Our product and industry analysis services provide market research insights on product demand, product adoption rates, and market constraints. We conduct research in fields such as chemicals, semiconductors, metals, and mining. We offer quantitative and qualitative data on market trends, forecasts, size, share, growth factors, and CAGR. We serve many leading companies and provide support to a wide range of players in the Japanese market to achieve the best results. We have helped companies seize opportunities not only in Japan but also in both developed and developing countries (Europe, Middle East, USA). Thanks to the services we provide, various players in the Japanese market have established exemplary positions in global niche markets. This demonstrates the value of the services we have offered throughout Japan. Our advanced research analysis provides solutions for companies to access the best data analysis and market intelligence relevant to their respective markets.
Company information
Our researchers conduct in-depth statistical surveys on the past, present, and future, generating forecasts on future scenarios related to market research reports, analytical insights, and almost every conceivable field relevant to our valued entrepreneurial clients and public institutions. Our analysts, consultants, and associates are experts in their respective fields and have strengthened core work ethics through extensive research and analytical capabilities. We are committed to supporting connections with the ever-evolving landscape of information, knowledge, and wisdom.
![[Research Material] Global Market for Respiratory Syncytial Virus Diagnostics](https://image.mono.ipros.com/public/product/image/d79/2001481431/IPROS88649373849879817110.jpeg?w=280&h=280)
![[Research Material] The Global Market for Pediatric Cardiac Tumor Diagnosis](https://image.mono.ipros.com/public/product/image/034/2001467304/IPROS48023138523334992774.jpeg?w=280&h=280)
![[Research Material] The Global Market for Computer-Aided Diagnosis (CADx)](https://image.mono.ipros.com/public/product/image/078/2001481023/IPROS02959329310443138680.jpeg?w=280&h=280)
